Libertyville, IL, United States of America

Gary A Gintant


 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Gary A. Gintant: Advancing Cardiac Research Through Patented Technology

Introduction: Gary A. Gintant, based in Libertyville, IL, is an accomplished inventor with a focus on the intersection of pharmacology and cardiac cellular research. With a significant contribution to the field through his patent, Gintant has demonstrated a commitment to advancing medical science, specifically in understanding the effects of substances on living cardiac cells.

Latest Patents: Gintant holds a patent for a "High throughput, optical method and system for determining the effect of a test substance on non-contiguous living cells." This innovative technology provides a rapid and efficient method for detecting various effects of substances, including electrophysiologic and proarrhythmic responses in native cellular cardiac preparations. It specifically enhances the ability to assess how chemicals, compounds, and drugs affect cardiac repolarization, contractility, and excitability utilizing optically based techniques and tailored simulation protocols.

Career Highlights: Gary A. Gintant is currently associated with AbbVie Inc., a global biopharmaceutical company renowned for its pharmaceuticals and commitment to advancing healthcare solutions. His work emphasizes the integration of cell-based pharmacologic responses to facilitate groundbreaking research in cardiac health.

Collaborations: Throughout his career, Gintant has collaborated with notable professionals, including Jonathan D. Trumbull and Stanislaw Kantor. These partnerships strengthen the research community's ability to innovate and address complex challenges within cardiac pharmacology.

Conclusion: Gary A. Gintant exemplifies the spirit of innovation in the field of cardiac research. With his patented methods and collaborative efforts at AbbVie Inc., he continues to pave the way for advancements that have the potential to significantly enhance our understanding of drug effects on cardiac cells and improve therapeutic outcomes. His contributions are vital to both the scientific community and public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…